Los puntos clave no están disponibles para este artículo en este momento.
Abstract I will introduce the Cancer Dependency Map (DepMap) project. This project aims to build a resource to identify the landscape of cancer vulnerabilities by linking molecular alterations of tumors to gene dependencies or drug sensitivities. This resource is being used by scientists around the world and has made significant contributions to basic and translational cancer research. I will describe how we are building DepMap and the multiple components it requires. Additionally, I will discuss ongoing projects to expand DepMap, including screening next-generation models. I will also present how to identify potential therapeutic targets using DepMap data and the emerging types of targets. Lastly, I will highlight a recently identified synthetic lethal target in the ribosome rescue pathway in molecularly defined patient populations, demonstrating the power of DepMap in identifying such targets. Citation Format: Francisca Vazquez. Towards mapping the landscape of cancer vulnerabilities abstract. In: Proceedings of the AACR Special Conference in Cancer Research: Expanding and Translating Cancer Synthetic Vulnerabilities; 2024 Jun 10-13; Montreal, Quebec, Canada. Philadelphia (PA): AACR; Mol Cancer Ther 2024;23(6 Suppl):Abstract nr IA011.
Francisca Vázquez (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: